Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPY5R | Q15761 | 19/20 | 0.63 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.40 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.40 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.40 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5773128 | 0.85 | NPY5R (0.60) | NPY5R | |
| SCHEMBL5769526 | 0.84 | NPY5R (0.63) | NPY5RADORA3ADORA2AADORA2BADORA1 | |
| SCHEMBL5773508 | 0.83 | NPY5R (0.62) | NPY5R | |
| SCHEMBL5774044 | 0.80 | NPY5R (0.60) | NPY5R | |
| SCHEMBL5772401 | 0.79 | NPY5R (0.70) | NPY5R | |
| SCHEMBL5774852 | 0.77 | NPY5R (1.00) | NPY5R | |
| SCHEMBL5776765 | 0.77 | NPY5R (0.51) | NPY5R | |
| SCHEMBL5771479 | 0.76 | NPY5R (0.57) | NPY5R | |
| Hydrochloric Acid SCHEMBL5775078 | 0.76 | NPY5R (0.96) | NPY5R | |
| SCHEMBL5772102 | 0.71 | NPY5R (0.60) | NPY5R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1054887-B1 | BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | AMGEN INC (US) | 2006-04-12 | — | — | EP | disclosed |
| US-6583154-B1 | Neuropeptide Y antagonist; pyrrolo-(3,2-b)pyridines and pyrrolo-(3,2-d)pyrimidines | AMGEN INC. | 2003-06-24 | — | — | US | disclosed |
| US-6187777-B1 | PYRROLO(3,2-D)PYRIMIDINE DERIVATIVES; NEUROPEPTIDE Y AND CORTICOTROPIN RELEASING FACTOR MODULATORS; DIETETICS; ANTIDIABETIC, ANTIINFLAMMATORY, AND ANTITUMOR AGENTS | AMGEN INC. | 2001-02-13 | — | — | US | disclosed |